By the Kryder Cares data team · Reviewed by Kris Kryder, licensed agent · Last updated
Medicare’s negotiated price is $197.00 for a 30-day supply of Jardiance and $178.50 for Farxiga, down from list prices of $573 and $556, in effect since January 1, 2026 under the Medicare Drug Price Negotiation Program. What you pay in 2027 is your plan’s copay or coinsurance, and your out-of-pocket spending on covered Part D drugs is capped at $2,400 for 2027.
This applies to Jardiance (empagliflozin) and Farxiga (dapagliflozin) through a Part D plan or a Medicare Advantage plan with drug coverage. Your cost depends on the tier your plan puts each drug on and whether you have met your deductible (up to $700 in 2027).
How it works: the negotiated price, the tier and the cap
The negotiated price is what your plan pays for the drug; it is not your bill. Your share comes from the tier your plan assigns. A tier is the price level a plan puts a drug on, and it usually means a set copay or a percentage of the price (coinsurance). Both drugs were among the first ten that Medicare negotiated, so the plan’s cost fell sharply in 2026, as the spending data below shows.
| Measure | Jardiance | Farxiga |
|---|---|---|
| CMS negotiated price, 30-day supply, 2026 | $197.00 | $178.50 |
| List price, 30-day supply | $573.00 | $556.00 |
| Discount from list price | 66% | 68% |
| People with Part D who used it, 2025 | 2,977,956 | 1,421,744 |
| Average Part D spending per prescription, 2025 | $1,091.19 | $997.75 |
| Average Part D spending per prescription, January to March 2026 (negotiated price in effect, quarterly release) | $386.83 | $328.97 |
Source: CMS fact sheet, negotiated prices for 2026; CMS Medicare Part D Spending by Drug (2025 and 2026 Q1). Pulled November 5, 2026. Spending per prescription is plan spending before manufacturer rebates and includes 90-day fills, so it is not what you pay.
- 2025 (full year) $1,091.19
- 2026 (Jan to Mar) $386.83
The drop reflects the negotiated price taking effect on January 1, 2026.
Source: CMS Medicare Part D Spending by Drug, pulled November 5, 2026.
What it costs you in 2027
Until you meet your plan’s deductible (up to $700 in 2027; some plans have less or none), you may pay the plan’s price for the drug. After that, you pay the tier copay or coinsurance. Once what you pay out of pocket for covered drugs reaches $2,400 in 2027, you pay $0 for covered Part D drugs for the rest of the year.
If you get Extra Help, you pay a small fixed copay for brand drugs instead. If large costs early in the year are hard on your budget, the Medicare Prescription Payment Plan lets you spread them into monthly payments through your plan. Ask for it when you enroll.
We have not loaded 2027 formulary tiers for these two drugs yet, so this page does not say how many plans cover them or on which tier. That is the first thing Kris checks in each plan.
What to do next
Send Kris your full drug list with doses and your pharmacy. She checks where Jardiance or Farxiga sits in each 2027 plan she represents and your total yearly cost, not just the premium, and enrolls you by December 7, 2026. You can also use the Rx drug lookup form.
Sources
We do not offer every plan available in your area. Currently we represent 14 organizations which offer 119 products in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options. This is a proprietary website and is not associated, endorsed or authorized by the Social Security Administration, the Department of Health and Human Services or the Center for Medicare and Medicaid Services. This site contains decision-support content and information about Medicare, services related to Medicare and services for people with Medicare. If you would like to find more information about the Medicare program please visit the Official U.S. Government Site for People with Medicare located at www.medicare.gov.
This answer is general education, not a recommendation for any specific plan. Figures were current as of November 5, 2026.